Adjuvant Webinar Series

The NIAID Adjuvant Webinar Series is a monthly virtual presentation given on current research relating to vaccine adjuvants. Each month a new speaker is invited to share their findings with the adjuvant research community. The overall goals of the webinar series are to publicize recent developments in the adjuvant field and to encourage collaboration between adjuvant researchers. Webinars take place on the fourth Tuesday of every month from 12:30 – 1:30 p.m. (ET), with a hiatus during the summer and winter. 

If you are interested in being invited to attend the NIAID Adjuvant Webinar Series, email a request to Ari Joffe.

Upcoming Webinars


Vaccine Adjuvants for Global Health – VFI’s Portfolio of Saponin-based Adjuvants

Celine Lemoine, Vaccine Formulation Institute
January 23, 2024

Precision Vaccines Program adjuvant portfolio

David Dowling, Boston Children’s Hospital
February 27, 2024

ACM-CpG adjuvant

Katherine Schultheis, ACM Biosciences
March 26, 2024

ASP-1 adjuvant

Sara Lustigman, New York Blood Center
April 23, 2024


May 28, 2024

Summer Break - June, July, and August

Yeast-derived squalene for use in vaccine adjuvants

Chase Kempinski, Enepret
September 24, 2024


October 22, 2024

Winter Break -November and December

Past Webinars;


Adjuvanticity of a novel TLR5 agonist;

KyungA Cho, Medispan
November 2, 2023

Securing the Supply Chain in Vaccine Adjuvants – Croda Pharma Adjuvant Systems

Dennis Christensen, Croda Pharma
September 26, 2023

Summer Break - June, July, and August

C-type Lectin Receptor Agonists

Kendal Ryter, University of Montana
May 23, 2023

LTA-1 Adjuvant

Betzi Norton, Tulane University
April 25, 2023

Outer Membrane Vesicles and Mucosal Immunity

Lisa Morici and James McLachlan, Tulane University
March 28, 2023

Consider the Adjuvant: Modifying Adjuvant Properties by Selective Alteration of Signaling Pathways

Dr. Aaron Esser-Kahn, University of Chicago
Feb 28, 2023

Carbohydrate fatty acid monosulphate esters are potent adjuvant molecules.

Dr. Luuk Hilgers, LiteVax BV (Oss, the Netherlands)
January 24, 2023

Winter Break - November and December


Update on BECC-based TLR4 ligands for use as vaccine adjuvants

Robert Ernst, University of Maryland
October 25, 2022

Opportunities to Test Immunomodulatory Compounds in Human Immune Organoids

Lisa Wagar, University of California, Irvine
February 22, 2022

Membrane-anchored Cytokines as Novel Vaccine Adjuvants for the Elderly

Chris Pack, Metaclipse
March 22, 2022

Adjuvant discovery using deep learning on high-dimensional phenomics

Matt Booty, Spring Discovery
April 26, 2022

Adjuvant Properties of the TLR 7/8 agonist 3M-052 in Various Animal Models

Mark Tomai and Chris Fox, 3M and AAHI
May 24, 2022

Summer Break - June, July, and August

Nucleoside-Modified mRNA-LNP Therapeutics

Drew Weissman, University of Pennsylvania
September 27, 2022

MAS-1 Adjuvant / Delivery System

Peter Blackburn, Mercia Pharma Inc.
October 25, 2022  

Winter Break - November and December

Content last reviewed on